Brief: Advaxis And UCLA Enter Collaboration For Glioblastoma Immunotherapy Discovery Research
10/10/2019 14:43
Oct 10 (Reuters) - Advaxis Inc ADXS.O :
* ADVAXIS AND UCLA ENTER COLLABORATION FOR GLIOBLASTOMA
IMMUNOTHERAPY DISCOVERY RESEARCH
Source text for Eikon: ID:nBwc0568Ra
Further company coverage: ADXS.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Ayala Pharmaceuticals
See all newsBrief: Ayala Pharmaceuticals Completes Sale Of AL102 To Immunome
Immunome slides on $200 mln equity offering
Immunome edges up after $200 mln equity offering
Brief: Immunome To Acquire AL102 Phase 3 Asset for the Treatment of Desmoid Tumors From Ayala Pharmaceuticals
Brief: Ayala Pharmaceuticals Announces AL102 Receives Orphan Drug Designation for Desmoid Tumors